SYSTEMATIC LITERATURE REVIEW OF NMAS AND POPULATION ADJUSTED INDIRECT COMPARISONS OF BIOLOGICAL TREATMENTS IN MODERATE-TO-SEVERE PSORIASIS

被引：0
|
作者：
Llinares, Garcia, I [1 ]
Hernando, T. [1 ]
Kohout, M. [2 ]
机构：
[1] Janssen, Madrid, Spain
[2] Janssen, Neuss, Germany
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI9
引用
收藏
页码：S419 / S419
页数：1
相关论文
共 50 条
  • [1] Biological treatments for moderate-to-severe psoriasis: indirect comparison
    Galvan-Banqueri, M.
    Marin Gil, R.
    Santos Ramos, B.
    Bautista Paloma, F. J.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (02) : 121 - 130
  • [2] On clinical thresholds, clinical equivalents and indirect comparisons of biological treatments for moderate-to-severe psoriasis
    Puig, L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (02) : 131 - 134
  • [3] Indirect comparison of anti-interleukin 17 targeted biological treatments for moderate-to-severe psoriasis
    Diaz Acedo, Rocio
    Galvan Banqueri, Mercedes
    Marquez Saavedra, Esther
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (04) : 715 - 721
  • [4] Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasis
    de la Cueva Dobao, P.
    Notario, J.
    Ferrandiz, C.
    Lopez Estebaranz, J. L.
    Alarcon, I
    Sulleiro, S.
    Borras, J.
    Dauden, E.
    Carrascosa, J. M.
    Sanchez Carazo, J. L.
    Monte Boquet, E.
    Puig, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (07) : 1214 - 1223
  • [5] SYSTEMATIC LITERATURE REVIEW OF NMAS OF BIOLOGICAL TREATMENTS INCLUDING USTEKINUMAB IN ULCERATIVE COLITIS
    Sulleiro, S.
    Mompo, C.
    Hernando, T.
    VALUE IN HEALTH, 2022, 25 (01) : S23 - S23
  • [6] Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review
    Alessio Gambardella
    Gaetano Licata
    Anne Sohrt
    Dermatology and Therapy, 2021, 11 : 1141 - 1156
  • [7] Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review
    Gambardella, Alessio
    Licata, Gaetano
    Sohrt, Anne
    DERMATOLOGY AND THERAPY, 2021, 11 (04) : 1141 - 1156
  • [8] Tildrakizumab for Moderate-to-Severe Chronic Plaque Psoriasis: a Review of the Literature
    Kory P. Schrom
    Avi Bitterman
    Neil J. Korman
    Current Dermatology Reports, 2019, 8 : 6 - 13
  • [9] Tildrakizumab for Moderate-to-Severe Chronic Plaque Psoriasis: a Review of the Literature
    Schrom, Kory P.
    Bitterman, Avi
    Korman, Neil J.
    CURRENT DERMATOLOGY REPORTS, 2019, 8 (01) : 6 - 13
  • [10] Matching-adjusted indirect treatment comparison of guselkumab and ixekizumab in patients with moderate-to-severe psoriasis
    Varu, Abhishek
    Cameron, Chris
    Diels, Joris
    Hutton, Brian
    McElligott, Sean
    Schubert, Agata
    van Sanden, Suzy
    Villacorta, Reggie
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB187 - AB187
12345